Millennium Management’s GSK GSK Stock Holding History

Millennium Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$26.4M	Sell	477,800 -171,600	-26%	-$9.3M	0.01%	1319
2025 Q4	$31.8M	Buy	649,400 +150,700	+30%	+$7.03M	0.01%	1136
2025 Q3	$21.5M	Buy	498,700 +385,900	+342%	+$15.1M	0.01%	1588
2025 Q2	$4.33M	Buy	112,800 +88,900	+372%	+$3.4M	﹤0.01%	3138
2025 Q1	$926K	Sell	23,900 -577,800	-96%	-$21.2M	﹤0.01%	4403
2024 Q4	$20.3M	Buy	601,700 +564,800	+1,531%	+$20.3M	0.01%	1502
2024 Q3	$1.51M	Sell	36,900 -796,000	-96%	-$32.6M	﹤0.01%	3954
2024 Q2	$32.1M	Buy	832,900 +280,900	+51%	+$11.8M	0.01%	1101
2024 Q1	$23.7M	Buy	552,000 +519,400	+1,593%	+$21.4M	0.01%	1428
2023 Q4	$1.21M	Sell	32,600 -125,200	-79%	-$4.49M	﹤0.01%	4001
2023 Q3	$5.72M	Sell	157,800 -192,300	-55%	-$6.83M	﹤0.01%	2577
2023 Q2	$12.5M	Sell	350,100 -8,700	-2%	-$312K	0.01%	1794
2023 Q1	$12.8M	Sell	358,800 -441,200	-55%	-$15.4M	0.01%	1729
2022 Q4	$28.1M	Buy	800,000 +350,000	+78%	+$11.7M	0.02%	1172
2022 Q3	$13.2M	Buy	450,000 +30,000	+7%	+$1.14M	0.01%	1806
2022 Q2	$22.9M	Buy	420,000 +220,000	+110%	+$12.1M	0.01%	1180
2022 Q1	$10.9M	Hold	200,000	–	–	0.01%	2066
2021 Q4	$11M	Sell	200,000 -80,000	-29%	-$4.16M	0.01%	2045
2021 Q3	$13.4M	Buy	+280,000	New	+$14.1M	0.01%	1707
2021 Q1	–	Sell	-160,000	Closed	-$7.36M	–	6148
2020 Q4	$7.36M	Buy	160,000 +40,000	+33%	+$1.84M	0.01%	2081
2020 Q3	$5.65K	Buy	+120,000	New	+$6.01M	0.01%	1726
2014 Q4	–	Sell	-1,040	Closed	-$60K	–	4052
2014 Q3	$60K	Sell	1,040 -5,120	-83%	-$314K	﹤0.01%	3588
2014 Q2	$412K	Buy	6,160 +2,080	+51%	+$141K	﹤0.01%	2702
2014 Q1	$272K	Buy	+4,080	New	+$276K	﹤0.01%	2996

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Millennium Management's GSK Position: Q1 2026 in Review

Millennium Management reduced its GSK (GSK) stake by 91% in Q1 2026, selling an estimated $2.14M and leaving 4,067 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #5133.

Millennium Management first reported a position in GSK in Q3 2013 and has held it in 49 quarters since. The position peaked at $156M in Q4 2022. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Millennium Management held 4,067 shares of GSK worth $224K as of Q1 2026.
Millennium Management sold 39,538 GSK shares in Q1 2026, an estimated $2.14M.
GSK made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5133 holding.
Millennium Management first reported a position in GSK in Q3 2013 and has held it in 49 quarters since.
Millennium Management's GSK position peaked at $156M in Q4 2022.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.